Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Novel therapeutic combinations with PARP inhibitors for small cell lung cancer: A bench-to-bedside review.
Semin Cancer Biol. 2022 Nov;86(Pt 2):521-542. doi: 10.1016/j.semcancer.2022.07.008. Epub 2022 Jul 30.
Semin Cancer Biol. 2022.
PMID: 35917883
Review.
PARP inhibitors for small cell lung cancer and their potential for integration into current treatment approaches.
Barayan R, Ran X, Lok BH.
Barayan R, et al.
J Thorac Dis. 2020 Oct;12(10):6240-6252. doi: 10.21037/jtd.2020.03.89.
J Thorac Dis. 2020.
PMID: 33209463
Free PMC article.
Review.
Item in Clipboard
Item in Clipboard
Targeting the Ubiquitin-Proteasome System Using the UBA1 Inhibitor TAK-243 is a Potential Therapeutic Strategy for Small-Cell Lung Cancer.
Majeed S, Aparnathi MK, Nixon KCJ, Venkatasubramanian V, Rahman F, Song L, Weiss J, Barayan R, Sugumar V, Barghout SH, Pearson JD, Bremner R, Schimmer AD, Tsao MS, Liu G, Lok BH.
Majeed S, et al. Among authors: barayan r.
Clin Cancer Res. 2022 May 2;28(9):1966-1978. doi: 10.1158/1078-0432.CCR-21-0344.
Clin Cancer Res. 2022.
PMID: 35165102
Free PMC article.
Item in Clipboard
Item in Clipboard
Cite
Cite